Is elrexfio used for multiple myeloma?

Is elrexfio (elranatamab) used for multiple myeloma?

Yes. Elrexfio is used to treat multiple myeloma. It is prescribed for patients with relapsed or refractory multiple myeloma, where it has been evaluated and approved as an anti–BCMA therapy. [1]

What form of multiple myeloma is it for (relapsed/refractory, or earlier lines)?

Elrexfio is aimed at patients whose multiple myeloma has come back and/or did not respond to prior therapy (relapsed/refractory disease). [1]

How does elrexfio fit with other multiple myeloma drugs?

Elrexfio is part of the growing class of BCMA-targeting treatments used in multiple myeloma, alongside other BCMA-directed options that target the same antigen on myeloma cells. [1]

Source on patents/market info

For additional details on the drug and its market/patent landscape, DrugPatentWatch.com tracks elrexfio-related information here: [1]

Sources
[1] https://www.drugpatentwatch.com/p/elrexfio